CAS 145096-30-6 is the registry number for E 3040. Offered by: MedChemExpress. Available pack sizes: Get quote.
E3040 is a member of the class of benzothiazoles that is 1,3-benzothiazole substituted by a methylnitrilo group, (pyridin-3-yl)methyl group, methyl group, hydroxy group and methyl group at position 2,4,5,6 and 7, respectively. It is a dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase and exhibits anti-inflammatory properties. The drug was being developed by Eisai (Tokyo, Japan) for the treatment of bowel disease. It has a role as an anti-inflammatory drug, a uricosuric drug and an EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor. It is a member of pyridines, an organic hydroxy compound, a member of benzothiazoles and a secondary amino compound.
Source: ChEBI
| Molecular formula | C16H17N3OS |
|---|---|
| Molecular weight | 299.4 g/mol |
| IUPAC name | 5,7-dimethyl-2-(methylamino)-4-(pyridin-3-ylmethyl)-1,3-benzothiazol-6-ol |
| InChIKey | IONAQTGMWFXHIX-UHFFFAOYSA-N |
| SMILES | CC1=C(C2=C(C(=C1O)C)SC(=N2)NC)CC3=CN=CC=C3 |
Computed by PubChem (NCBI)